ReNeuron Group (RENE)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.13
  • 52 Week Low: 3.38
  • Currency: UK Pounds
  • Shares Issued: 57.17m
  • Volume: 0
  • Market Cap: £1.93m
  • RiskGrade: 394

Regulatory News

Directorate Change 17-Apr-2024 11:30 RNS
Appointment of Administrators 20-Mar-2024 15:43 RNS
Intention to Appoint Administrators 20-Mar-2024 12:30 RNS
Block Listing Review & Total Voting Rights 01-Mar-2024 07:00 RNS
Suspension - ReNeuron Group plc 05-Feb-2024 14:30 RNS
Corporate update and suspension of trading on AIM 05-Feb-2024 14:30 RNS
Interim Results for the six months ended 30 Sept 08-Nov-2023 07:01 RNS
ReNeuron presents in vivo data at Cell 2023 08-Nov-2023 07:00 RNS
R&D Update 04-Sep-2023 07:00 RNS
Block Listing Review & Total Voting Rights 01-Sep-2023 07:00 RNS
Director declaration 29-Aug-2023 07:00 RNS
Result of AGM 22-Aug-2023 10:34 RNS
Notice of AGM 24-Jul-2023 17:20 RNS
Share Purchase by Chief Financial Officer 12-Jul-2023 11:57 RNS
Share Purchase by Senior Independent NED 16-Jun-2023 17:12 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

ReNeuron Group Market Data

Currency UK Pounds
Share Price 3.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.13
52 Week Low 3.38
Volume 0
Shares Issued 57.17m
Market Cap £1.93m
RiskGrade 394

ReNeuron Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.00% above the market average69.00% above the market average69.00% above the market average69.00% above the market average69.00% above the market average
1.89% above the sector average1.89% above the sector average1.89% above the sector average1.89% above the sector average1.89% above the sector average
Price Trend
89.91% below the market average89.91% below the market average89.91% below the market average89.91% below the market average89.91% below the market average
50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average
Income Not Available
Growth
6.10% above the market average6.10% above the market average6.10% above the market average6.10% above the market average6.10% above the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ReNeuron Group Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page